Patrick McCann, MD
Advanced Heart Failure and Transplant Cardiology · Columbia, SCNPI 1487850780
Payments from drug & device makers
Across 1,448 payments — averaging $951.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endotronix, Inc.$622K
- Abbott$251K
- Cvrx, Inc.$153K
- AstraZeneca$119K
- Novartis$93K
- American Regent$40K
- plus $100K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endotronix, Inc. | 6 | $622,194 |
| Abbott | 638 | $250,810 |
| Cvrx, Inc. | 171 | $153,222 |
| AstraZeneca | 152 | $119,431 |
| Novartis | 95 | $93,004 |
| American Regent | 9 | $39,700 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 32 | $29,998 |
| Medtronic(2 entities) | 19 | $24,927 |
| Johnson & Johnson | 23 | $11,757 |
| Lexicon Pharmaceuticals, Inc. | 12 | $10,175 |
| Actelion Pharmaceuticals, Ltd | 10 | $9,547 |
| Daxor Corporation | 5 | $4,066 |
| Ancora Heart, Inc. | 15 | $2,328 |
| Boston Scientific | 53 | $1,873 |
| Alnylam Pharmaceuticals Inc. | 37 | $670 |
| Abiomed | 12 | $625 |
| Pfizer | 24 | $586 |
| Actelion Pharmaceuticals US, Inc. | 20 | $441 |
| Merck | 24 | $435 |
| Boehringer Ingelheim | 22 | $415 |
| Impulse Dynamics (USA) Inc. | 15 | $388 |
| Philips North America LLC | 2 | $307 |
| Nuwellis, Inc. | 9 | $242 |
| Scpharmaceuticals Inc. | 11 | $189 |
| Novo Nordisk | 8 | $145 |
| Bayer | 7 | $120 |
| Nobel Biocare USA | 1 | $72 |
| Daiichi Sankyo Inc. | 3 | $59 |
| Amgen | 3 | $51 |
| E.r. Squibb & Sons, L.L.C. | 3 | $46 |
| Vifor Pharma, Inc. | 2 | $39 |
| Livanova USA, Inc. | 2 | $28 |
| Recor Medical Inc | 1 | $25 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $15 |
How this compares
$1,377,945 in reported general payments places this provider in the 95th percentile of 30 advanced heart failure and transplant cardiology providers in South Carolina.
See all advanced heart failure and transplant cardiology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Columbia
- Rebecca NapierColumbia$235K
- James AmpaduColumbia$207K
- Cassandra Buto-CollettiColumbia$21K
- Joshua ConeyColumbia$14K
- Barry FeldmanColumbia$12K
- Michael RofaelColumbia$11K
- Jason GuichardGreenville$4.3M
- Daniel SilvermanCharleston$1.2M
- Sheldon LitwinCharleston$1.1M
- Ryan TedfordCharleston$590K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.